Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.11%, DAX +0.12%, CAC40 +0.09%

Dec 12 ,2023

  • Synopsis

    • European equity markets set for a positive open amidst Asian equities mostly higher Tuesday. US CPI to take spotlight later ahead of Federal Reserve meeting.

    • European macro data releases on the calendar include Netherlands Nov CPI +1.6% y/y vs preliminary +1.6%. Also due today, Germany Dec ZEW economic sentiment, UK Nov claimant count, Oct unemployment rate, Netherlands Nov final CPI

    • Also on today's agenda, On Tue, EU Council of Ministers for General Affairs meeting. South Korean President Yoon Suk Yeol pays state visit to The Netherlands. In UK, parliamentary committee topics include work of the Financial Conduct Authority (10:15GMT), MoD Annual Report and Accounts (10:30), National Infrastructure Commission (10:30), UK's new relationship with the EU (14:00), implications of Russia's invasion of Ukraine for UK-EU relations (15:00). Norway's PM Støre is present at the awarding of the Nobel Peace Prize. European Banking Authority (EBA) to release its 2023 Risk Assessment Report and transparency exercise with bank by bank data at 18:00CET.

    • In central banks, Riksbank's Jansson speech at 8:00CET at an event organised by Danske Bank. ECB's McCaul speech at 14:30CET at event organised by European American Chamber of Commerce New York

    • In earnings news, Nokia (NOKIA.FH) lowered its comparable operating margin target to be achieved by 2026 from prior of "at least 14%" to at "least 13%" and issued planning assumptions for 2024. Carl Zeiss Meditec (AFX.GR) reported FY earnings and reaffirmed that in the medium term, the Company expects to be able to stabilize its EBIT margin sustainably above 20%. Wendel (MF.FP) announced long term targets and dividend increase ahead of tomorrow's investor day.

    • Also due to report today, Colruyt Group (COLR.BB), Genmab (GMAB.DC) R&D, Hannover Re (HNR1.GR), VINCI (DG.FP), HomeToGo (HTG.GR), Vitrolife (VITR.SS) and Chemring Group (CHG.LN).

  • Politics/Macro/World News

    • EU

      • ECB Must Cement Its QT Plans to Avoid Confusing Markets - Bloomberg

      • EU explores emergency Ukraine funding outside bloc's shared - FT

    • UK

      • London to Lead Long-Awaited Slowdown in UK Rent Growth Next Year - Bloomberg

      • UK business in China sees 2024 as 'pivotal' for investment - FT

      • Rishi Sunak seeks to charm Tory MPs to avoid Rwanda split - BBC

    • Denmark

      • Denmark's Government Lowers 2023, 2024 Financing-Need Estimates - Bloomberg

    • France

      • French central bank sees fourth quarter growth of 0.1% - Reuters

  • Top company news

    • Earnings/updates

      • NOKIA.FH (Nokia) -- lowers comparable operating margin target to be achieved by 2026 from prior "at least 14%" to at "least 13%"; issues planning assumptions for 2024 -- CMD

      • MF.FP (Wendel) -- announces long term targets and dividend increase ahead of tomorrow's investor day

      • REDD.LN (Redde Northgate) -- StreetAccount Earnings Call Q&A Summary: Redde Northgate Q2

      • SCHP.FP (Seche Environnement) -- confirms 2023 targets, presents financial and non-financial 2026 trajectory at Investors Day on 12-Dec-23

      • AFX.GR (Carl Zeiss Meditec) -- reports FY EPS €3.25 vs FactSet €2.96

      • Also due to report today:

        • Earnings:

          • Benelux: Colruyt Group (COLR.BB)

          • France: Figeac Aero (FGA.FP)

          • Nordics: Harboes Bryggeri (HARB.B.DC), Agat Ejendomme (AGAT.DC)

          • UK: Chemring Group (CHG.LN)

        • Trading Update: DFDS (DFDS.DC), Groupe Partouche (PARP.FP)

        • Traffic: Flughafen Zurich (FHZN.SW)

        • CMD/events: Genmab (GMAB.DC) R&D, Hannover Re (HNR1.GR), VINCI (DG.FP), HomeToGo (HTG.GR), Vitrolife (VITR.SS)

    • M&A

      • SAN.FP (Sanofi) -- Sanofi terminates license agreement with Maze Therapeutics following FTC challenge

      • VIV.FP (Vivendi) -- announces approval of the extension of the exercise period of the rights to sell Lagardère shares to 15-Jun-25

      • BNP.FP (BNP Paribas) -- Mirae Asset Securities to acquire Sharekhan for KRW487.26B (€343.9M) (09:55 KT/01:55 CET)

      • SXS.LN (Spectris) -- announces the sale of Red Lion Controls to HMS Networks (HMS) for $345M (£286M)

      • EQT.SS (EQT AB) -- EQT Infrastructure to acquire a majority position in Heritage Environmental Services for undisclosed terms

      • HMS.SS (HMS Networks) -- acquires Red Lion Controls for a cash consideration of $345M (~ SEK 3.6B), on a cash and debt free basis

      • EFUEL.NO (Everfuel) -- NEL ASA to sell all its 11.7M shares in Everfuel for a total consideration of NOK 116.6M, equal to NOK 9.97/share

      • RISH.NO (GC Rieber Shipping) -- Oslo Børs decides to delist the shares of GC Rieber Shipping ASA; last day of trading will be 13-Dec

      • GPG Australia appoints Morgan Stanley to review options - Australian Financial Review

    • Healthcare

      • BMY (Bristol Myers Squibb) -- issues updated results from three programs at ASH

      • LLY (Eli Lilly) -- presents updated data from Phase 1/2 BRUIN trial of pirtobrutinib at ASH

      • MEIP (MEI Pharma) -- reports clinical data on oral CDK9 inhibitor Voruciclib alone and in combination with Venclexta at ASH2023

      • IRON (Disc Medicine) -- presents positive updated results from Phase 2 BEACON study of Bitopertin at ASH

    • Other

      • German insurers including Allianz and Munich Re have amassed more than €3B exposure to struggling Signa property empire - FT

      • ENX.FP (Euronext) -- Deutsche Börse approached Euronext about creating new tech exchange somewhere in Europe - FT

      • CO.FP (Casino Guichard-Perrachon) -- Paris Commercial Court extends for further two months (from 25-Dec-23 to 25-Feb-24) accelerated safeguard procedures initiated on 25-Oct-23 for Casino, Guichard-Perrachon and its six subsidiaries concerned

      • MAREL.IR (Marel) -- appoints Arni Sigurdsson as CEO; effective immediately

      • Venezuela contacting energy firms regarding idled offshore natural gas project - Reuters

  • Key rating changes

    • Upgrades

      • KOJAMO.FH (Kojamo) -- to neutral from underweight at JPMorgan

      • RIO.LN (Rio Tinto) -- to overweight from neutral at JPMorgan

      • NHY.NO (Norsk Hydro) -- to overweight from underweight at JPMorgan

      • MT.NA (ArcelorMittal) -- to overweight from neutral at JPMorgan

      • VMUK.LN (Virgin Money UK) -- to outperform from neutral at Macquarie

    • Downgrades

      • HO.FP (Thales) -- to neutral from buy at Citi

      • ELE.SM (Endesa) -- to hold from buy at Societe Generale

      • ROCK.B.DC (Rockwool) -- to sell from neutral at Goldman Sachs

      • SCATC.NO (Scatec) -- to sell from hold at DnB Markets

      • VGP.BB (VGP SA) -- to underweight from neutral at JPMorgan

    • Others

      • SIGHT.FP (GenSight Biologics) -- GenSight Biologics resumed hold at Kepler Cheuvreux; prior rating was buy

  • Data

    • Nikkei +0.16% to 32843.70

    • Hang Seng +1.05% to 16372.23

    • Shanghai Composite +0.28% to 2999.89

    • S&P futures +0.8 vs prior close of 4678.5

    • €-$ +0.0010 or +0.09% to 1.0774

    • $-¥ (0.73) or (0.50%) to 145.43

    • €-¥ (0.63) or (0.40%) to 156.69

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE